Hyasynth

Despite its increasing popularity in medicine, Cannabis is too costly to produce at large scale with the quality and consistency needed for medical use. Instead of depending on the cannabis plant and breeding new strains, we use engineered yeast to produce the same products, including THC, CBD and even many of the minor cannabinoids, which are only found in small quantities in the plant. Compared to plants, our process is expontentially cheaper, faster and reaches the quality that patients, doctors and researchers can depend on.

COMPANY PEOPLE

Shoham Mookerjee

Shoham Mookerjee
CTO & Co-Founder

Alex Campbell

Alex Campbell
CSO & Co-Founder

Kevin Chen

Kevin Chen
CEO & Co-Founder

Zach Wiltshire

Zach Wiltshire
COO & Co-Founder

YOU MIGHT ALSO BE INTERESTED IN

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.